COMMUNIQUÉS West-GlobeNewswire
-
NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET
17/04/2026 -
Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details
17/04/2026 -
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
17/04/2026 -
Dogecoin Cash, Inc. (OTCQB: DOGP) Announces Development Initiative for “Dogecoin Gold” Digital Asset Framework
17/04/2026 -
Genmab A/S Share Capital Reduction
17/04/2026 -
Yuhua Zhang, PhD, Named Chairholder of the Carolyn and Chuck Miller Endowed Chair for Vision Research
17/04/2026 -
Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome
17/04/2026 -
SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson
17/04/2026 -
Global Widget Celebrates 10 Years as a Leader in Premium Gummy Manufacturing
17/04/2026 -
Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine
17/04/2026 -
First Steps Developmental Services Expands Services in Woburn
17/04/2026 -
Omada Health Helps Members on GLP‑1s Lose More Fat, Preserve Muscle Mass, and Improve Mental Health, New Study Finds
17/04/2026 -
Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
17/04/2026 -
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC
17/04/2026 -
Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital
17/04/2026 -
Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
17/04/2026 -
Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors
17/04/2026 -
BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting
17/04/2026 -
Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network
17/04/2026
Pages